Details
Title
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
Author
Ranzenigo, M; Gianotti, N
; Galli, L; Poli, A; Mastrangelo, A; Bruzzesi, E; Chiurlo, M; Nozza, S; Bossolasco, S; Spagnuolo, V
; Mancusi, D
; Termini, R
; Carini, E; Lazzarin, A; Castagna, A
; Galli, L; Poli, A; Mastrangelo, A; Bruzzesi, E; Chiurlo, M; Nozza, S; Bossolasco, S; Spagnuolo, V
; Mancusi, D
; Termini, R
; Carini, E; Lazzarin, A; Castagna, APages
3737-3738
Section
Corrigendum
Publication year
2022
Publication date
2022
e-ISSN
1177-8881
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2737206147
Copyright
© 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.